Investor Profile: HealthKois — Thesis, Cheque Size & How to Apply

HealthKois funding targets one of India's hardest problems: a fragmented healthcare system where access, affordability and quality still fail millions. For founders asking how to get funding from HealthKois, the bar is clear: technology-led, early-growth healthcare companies with demonstrable clinical outcomes, scalable operations and sustainable infrastructure models. Launched in June 2025 by the core leadership behind HealthQuad, it is positioned as India's premier healthcare transformation fund.

Thesis and investment focus

HealthKois backs companies using technology and innovative business models to resolve India's most pressing healthcare challenges. Managing partner Charles Janssen has said the mission is to support early-growth companies leveraging technology to fix those gaps, claiming over 75% proprietary deal flow as an edge. Artificial intelligence is a strong theme across all five focus areas, according to co-founder Ajay Mahipal.

Sectors, stages and cheque size

HealthKois invests in early-growth businesses across healthtech, life sciences, medtech, healthcare delivery and climate health. Roughly 50% of capital is earmarked for healthtech, with 10% to 15% each for biopharma, medtech, healthcare delivery and climate health. Cheques are substantial: $7 million to $25 million per company, deployed over four years across a planned portfolio of 13 to 16 ventures. It is a growth-stage investor, suited to companies with clinical validation and deployment traction that need capital to scale across India.

Fund size and track record

HealthKois launched with a target corpus of $300 million, plus a $100 million greenshoe option, taking the potential total to $400 million. Later coverage describes it as HealthKois (Fund III), successor to HealthQuad Funds I and II. That legacy is the track record to weigh: HealthQuad Funds I and II reportedly backed companies that touched over 90 million lives and serve 8.2 million patients annually. HealthKois has also co-authored a BCG report on India's life sciences sector.

Notable portfolio

No portfolio company names for the new HealthKois fund itself could be verified from public announcements, so none are invented here. What the fund says it seeks is clear: businesses with robust operational scalability, demonstrable clinical outcomes and sustainable infrastructure solutions. HealthKois builds on the HealthQuad legacy while widening the lens to climate health, where healthcare and environmental outcomes increasingly overlap.

Partners and programmes

HealthKois was founded by Charles Janssen as managing partner, with partners Ajay Mahipal and Dr Pinak Shrikhande, the key leadership team behind HealthQuad. Launch coverage describes a hands-on, founder-first approach, with capital offered alongside strategic guidance, market expansion support and governance planning, and long combined experience across clinical care, operations and healthcare investing in Asia and Europe. No accelerator programme run by HealthKois itself could be verified.

How to apply for funding from HealthKois

No public application form for HealthKois could be verified, so approach through the healthcare investment networks the team is known in, ideally with a warm introduction from a clinician, operator or existing healthcare investor. Lead with evidence: clinical outcomes data, unit economics, regulatory standing and a deployment plan for a $7 million to $25 million cheque. Show which focus area the company sits in, how artificial intelligence genuinely improves the product, and what measurable impact on access, affordability or quality it delivers. Growth-stage funds move on proof, so traction matters more than vision alone.